EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Clinical Associations with Hospital Escalation Among COVID-19 Patients Receiving Remdesivir in a Hospital-at-Home Service: A Real-World Cohort Study

Manuel Mirón-Rubio iD, Regina de la Corte-Carmona, Amaya Palomo-Iloro, Eduardo Fernández-Carracedo, José Ramón Sevilla-Resúa, Santiago Somovilla-Moreno, Isabel Ortega-Fernández, Francisco Bas-Sanchís, María Del Carmen Montero-Hernández iD, Irene Gutiérrez-Gómez, Rocío Estepa-Sánchez, Eduardo Oliveros-Acebes

Journal of Clinical Medicine · 24.09.2025 · 14 (19) · 6736

DOI: 10.3390/jcm14196736 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 24.09.2025. Verfasst von Manuel Mirón-Rubio und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hospital-at-Home Service, Hospital Universitario de Torrejón, Torrejón de Ardoz, 28850 Madrid, Spain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences (Spain), Fundación Ribera Salud through a donation from Gilead Sciences (Spain).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Hospital-at-home (HaH) programs expanded hospital capacity during the COVID-19 pandemic, but data on which HaH patients receiving intravenous (IV) remdesivir may require hospital escalation is limited. We therefore aimed to explore clinical characteristics associated with escalation to inpatient care.

Methods

Single-center, retrospective cohort of adults with confirmed COVID-19 who received IV remdesivir via a HaH service was employed (September 2020–September 2024). Primary outcome was hospital escalation. Associations between baseline variables and escalation were assessed with bivariate statistics.

Results

Seventy-eight HaH episodes were analyzed. Hospital escalation occurred in 4 cases (5.1%); 30-day readmission after HaH discharge occurred in 4 additional cases (5.1%). Immunosuppression and persistent COVID-19 were significantly associated with escalation (p = 0.03 and p < 0.001, respectively). Patients who escalated underwent more frequent blood testing and had longer HaH stays. Classical comorbidities (age, hypertension, diabetes, obesity, pulmonary disease) were not associated with escalation. No remdesivir discontinuations due to adverse events were recorded.

Conclusions

In this real-world HaH cohort, IV remdesivir was well tolerated with low escalation and readmission rates. Immunosuppression and persistent COVID-19 showed significant associations with escalation, suggesting the need for refined selection and closer monitoring in these subgroups. Findings are exploratory and hypothesis-generating given the small number of events.

Schlagwörter

Stichwörter der Autor:innen

COVID-19escalation of carehospital-at-homeimmunosuppressionlactate dehydrogenasepersistent COVID-19readmissionremdesivir

Autor:innen und Institutionen

  • Hospital-at-Home Service, Hospital Universitario de Torrejón, Torrejón de Ardoz, 28850 Madrid, Spain.
  • Facultad de Medicina, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, Spain.
  • Internal Medicine Service, Hospital Universitario Severo Ochoa, Leganés, 28914 Madrid, Spain.
  • Internal Medicine Service, Hospital Universitario de Torrejón, Torrejón de Ardoz, 28850 Madrid, Spain.

ORCID-Profile: Manuel Mirón-Rubio, María Del Carmen Montero-Hernández

Förderung

  • Gilead Sciences (Spain)
  • Fundación Ribera Salud through a donation from Gilead Sciences (Spain)

Zitieren

APA

Mirón-Rubio, M., de la Corte-Carmona, R., Palomo-Iloro, A., Fernández-Carracedo, E., Sevilla-Resúa, J. R., Somovilla-Moreno, S., Ortega-Fernández, I., Bas-Sanchís, F., Montero-Hernández, M. D. C., Gutiérrez-Gómez, I., Estepa-Sánchez, R., & Oliveros-Acebes, E. (2025). Clinical Associations with Hospital Escalation Among COVID-19 Patients Receiving Remdesivir in a Hospital-at-Home Service: A Real-World Cohort Study. Journal of Clinical Medicine, 14(19), 6736. https://doi.org/10.3390/jcm14196736

Vancouver

Mirón-Rubio M, de la Corte-Carmona R, Palomo-Iloro A, Fernández-Carracedo E, Sevilla-Resúa JR, Somovilla-Moreno S, et al. Clinical Associations with Hospital Escalation Among COVID-19 Patients Receiving Remdesivir in a Hospital-at-Home Service: A Real-World Cohort Study. Journal of Clinical Medicine. 2025;14(19):6736. doi:10.3390/jcm14196736

BibTeX
@article{MirnRubio2025,
  author = {Mirón-Rubio, Manuel and de la Corte-Carmona, Regina and Palomo-Iloro, Amaya and Fernández-Carracedo, Eduardo and Sevilla-Resúa, José Ramón and Somovilla-Moreno, Santiago and Ortega-Fernández, Isabel and Bas-Sanchís, Francisco and Montero-Hernández, María Del Carmen and Gutiérrez-Gómez, Irene and Estepa-Sánchez, Rocío and Oliveros-Acebes, Eduardo},
  title = {Clinical Associations with Hospital Escalation Among COVID-19 Patients Receiving Remdesivir in a Hospital-at-Home Service: A Real-World Cohort Study},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {19},
  pages = {6736},
  doi = {10.3390/jcm14196736}
}
Kostenlos starten →